검색어: sui (영어 - 몰타어)

‘sui’
“sui”

model sui
mudell sui

sui generis decision
deċiżjoni sui generis

decision (sui generis)
deĊiŻjoni (sui generis)

exceptions to the sui generis right
eċċezzjonijiet għad-dritt sui generic

you know, the eu is a sui generis construction”.
għandek tkun taf li l-ue hija struttura li ma tistax tqabbilha ma xejn."

article 11 beneficiaries of protection under the sui generis right
l-artikolu 11 benefiċjarji ta’ protezzjoni skond id-dritt sui generic

other council acts, such as sui generis decisions or resolutions.
atti oħra tal-kunsill, bħal ma huma deċiżjonijiet jew riżoluzzjonijiet sui generis.

for sui, the recommended dose of ariclaim is 40 mg twice a day.
għal sui, id- doża rakkomandata ta 'ariclaim hija 40 mg darbtejn kuljum.

yentreve has been studied in a total of 2,850 women with sui.
yentreve ġie studjat f' total ta '2, 850 mara b' sui.

for sui, the recommended dose of duloxetine boehringer ingelheim is 40 mg twice a day.
għal sui, id- doża rakkomandata ta 'duloxetine boehringer ingelheim hija 40 mg darbtejn kuljum.

prizes, until now treated as grants sui generis, will receive greater attention.
il-premjijiet, li sa issa dejjem ġew trattati bħala għotjiet sui generis, se jingħataw aktar attenzjoni.

for the treatment of sui, ariclaim has been studied in a total of 2,850 women.
għat- trattament ta 'sui, ariclaim ġie studjat f' total ta' 2, 850 mara.

for the treatment of sui, duloxetine boehringer ingelheim has been studied in a total of 2,850 women.
għat- trattament ta 'sui, duloxetine boehringer ingelheim ġie studjat f' total ta' 2, 850 mara.

yentreve is used to treat moderate to severe stress urinary incontinence (sui) in women.
yentreve jintuża għat- trattament ta 'l- inkontinenza urinarja minn sforz (sui - stress urinary incontinence) minn moderata għal gravi fin- nisa.

sui is accidental leaks of urine during physical exertion or when coughing, laughing, sneezing, lifting or exercising.
sui sseħħ meta l-awrina tiskappa involontarjament matul l-isforz fiżiku jew wara li tisgħol, tidħaq, tagħtas, tgħolli oġġetti jew tagħmel eżerċizzji fiżiċi.

yentreve is a medicine to be taken by mouth to treat stress urinary incontinence (sui) in women.
yentreve huwa prodott mediċinali li jittieħed mill-ħalq għal kura ta’ inkontinenza awrinarja minħabba sforz (sui) fin-nisa.

for the purposes of this regulation, the term intellectual property rights means copyright, related rights, sui generis right for the protection of databases and industrial property rights.
għall-finijiet tar-regolament preżenti, l-espressjoni drittijiet ta’ proprjetà intellettwali tfisser id-dritt ta’ l-awtur, id-drittijiet anċillari, id-dritt sui generis għall-ħarsien tad-databases kif ukoll id-drittijiet ta’ proprjetà industrijali.

ariclaim is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui), (see section 5.1).
4. 1 indikazzjonijiet terapewtiċi